Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Trans-Pacific Trade Agreement: GPhA, NGOs Oppose Proposed IP Provisions
Implications of the Patent Pool Licenses with Gilead
Trans-Pacific Partnership Agreement: Did U.S. Move Threaten Public Health?
Brazilian Patent Office Rejects Gilead’s Divisional Application for Tenofovir Disoproxil Fumarate
Abbott Abandons Several Patent Applications in India
Indian political will to be put to the test as Cipla seeks Isentress voluntary license
Tahir Amin Speaks to NDTV About the Recent Victory Against Abbott Laboratories HIV Drug Patent
WTO, WIPO and WHO Examine Role of Patent Information in Access to Medicines
Drug company’s loss could be Africa’s gain
India rejects US company’s patent for anti-HIV drugs